April 17, 2018 In Business Events M·CAM Releases Patently Obvious®: AstraZeneca Several U.S. companies have encouraged the government of the United States to recite sweeping allegations of the “theft” of intellectual property by the Chinese. In the interest of a more complete conversation about U.S. innovation, M·CAM has conducted a series of commercial fitness reviews of the patents held by several companies. Read the full report on AstraZeneca here.
Sorry, the comment form is closed at this time.